BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 4, 2021
View Archived Issues
New phase I/II study of bintrafusp alfa with M-9241 and docetaxel in metastatic prostate cancer
Read More
Movement strengthens bones, and immunity
Read More
Atherosclerosis precedes clonal hematopoiesis
Read More
Ascendis initiates phase III trial of TransCon PTH for hypoparathyroidism
Read More
PIPE-307 enters phase I development as potential treatment of multiple sclerosis
Read More
Cancer-associated fibroblasts influence GIST progression and metastasis through PDGFC secretion
Read More
GcgR antagonist enhances functional beta-cell mass and glycemic control in type 1 diabetes
Read More
Topline data from BRAVE-AA2 phase III study of baricitinib in severe alopecia areata
Read More
MediciNova discontinues development of vaccine for COVID-19
Read More
FDA accepts IND application for EP-7041 for thrombosis prevention in patients with COVID-19
Read More
Guangdong Xiangxue Life Sciences patents TCRs targeting AFP-derived short peptide
Read More
New IRAK-4 inhibitors identified at Bristol Myers Squibb
Read More
Alkermes presents new mu-opioid receptor agonists
Read More
Ankh Life Sciences describes new anticancer compounds
Read More
Xentria submits IND application to the FDA for XTMAB-16 as treatment of sarcoidosis
Read More
Arbutus Biopharma identifies HBsAg secretion inhibitors
Read More
Wellmarker Bio receives phase I study approval for WM-S1-030 in Australia
Read More
Galapagos reports interim data from safety studies of filgotinib
Read More
Positive topline data from phase II program of AZR-MD-001 in Meibomian gland dysfunction
Read More
PHA-022121 shows promise for treating hereditary angioedema
Read More
Benralizumab achieves OCS elimination or reduction in OCS-dependent asthmatics
Read More
MiR-939-5p, tumor suppressor and potential therapeutic target in TNBC
Read More
FDA clears IND for pilot study of NVD-003 for congenital pseudarthrosis of the tibia
Read More
FDA clears initiation of phase I study of DT-2216 for solid tumors
Read More
COVID-eVax vaccine enters phase I/II study
Read More
CFI-402257 plus paclitaxel shows manageable safety in HER2-negative breast cancer patients
Read More
Nuformix reports preclinical data on NXP-002 in combination therapy for IPF
Read More
"Confounders" could be bountiful harvest rather than nuisance in epigenomics
Read More